Michael Serby
Overview
Explore the profile of Michael Serby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu H, Michmerhuizen M, Lao Y, Wan K, Salem A, Sawicki J, et al.
Drug Metab Dispos
. 2016 Dec;
45(3):294-305.
PMID: 27993930
Venetoclax (ABT-199), a B-cell lymphoma-2 (Bcl-2) protein inhibitor, is currently in clinical development for the treatment of hematologic malignancies. We characterized the absorption, metabolism, and excretion of venetoclax in humans....
2.
Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans
Shen J, Serby M, Surber B, Lee A, Ma J, Badri P, et al.
Drug Metab Dispos
. 2016 May;
44(8):1148-57.
PMID: 27179128
Ombitasvir (also known as ABT-267) is a potent inhibitor of hepatitis C virus (HCV) nonstructural protein 5A (NS5A), which has been developed in combination with paritaprevir/ritonavir and dasabuvir in a...
3.
Shen J, Serby M, Reed A, Lee A, Zhang X, Marsh K, et al.
Drug Metab Dispos
. 2016 May;
44(8):1164-73.
PMID: 27179127
Paritaprevir (also known as ABT-450), a potent NS3-4A serine protease inhibitor [identified by AbbVie (North Chicago, IL) and Enanta Pharmaceuticals (Watertown, MA)] of the hepatitis C virus (HCV), has been...
4.
Shen J, Serby M, Reed A, Lee A, Menon R, Zhang X, et al.
Drug Metab Dispos
. 2016 May;
44(8):1139-47.
PMID: 27179126
Dasabuvir [also known as ABT-333 or N-(6-(3-(tert-butyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl)naphthalen-2-yl)methanesulfonamide] is a potent non-nucleoside NS protein 5B polymerase inhibitor of the hepatitis C virus (HCV) and is being developed in combination with paritaprevir/ritonavir...
5.
Tabert M, Liu X, Doty R, Serby M, Zamora D, Pelton G, et al.
Ann Neurol
. 2005 Jun;
58(1):155-60.
PMID: 15984022
University of Pennsylvania Smell Identification Test data from control subjects (n = 63), patients with mild cognitive impairment (n = 147), and patients with Alzheimer's disease (n = 100) were...
6.
7.
Samuels S, Brickman A, Burd J, Purohit D, Qureshi P, Serby M
Mt Sinai J Med
. 2004 Feb;
71(1):55-62.
PMID: 14770251
Depression has frequently been cited as a manifestation of dementia with Lewy bodies (DLB). Previous studies have suggested an increase of depression in patients with DLB, compared to those with...
8.
Serby M
CNS Spectr
. 2003 Aug;
8(8):612-3.
PMID: 12907924
An 82-year-old man with treatment-resistant depression and early Alzheimer's disease was started on methylphenidate. Significant obsessive-compulsive behavior ensued but diminished over several weeks when methylphenidate was replaced by fluvoxamine. The...
9.
Serby M
Am J Psychiatry
. 2003 Aug;
160(8):1527-9.
PMID: 12900321
Objective: To explore the ways in which psychiatry residents conceptualize the terms "mood" and "affect," a 14-item questionnaire was sent to residency programs in New York. Method: The questions consisted...
10.
Serby M, Schmeidler J, Smith J
Acad Psychiatry
. 2003 Jun;
26(2):102-4.
PMID: 12824151
The authors assessed the extent of change in the length of psychiatry clerkships in U.S. medical schools from 1995-1996 to 1998-1999 and explored the relationship between clerkship length and percentage...